Myocardial Perfusion Quantification With SPECT Using Multi-Pinhole Collimator Compared to Photon-Counting Coronary CTA

Recruiting N/A Interventional Study
Coronary Artery Disease Coronary Computed Tomography Angiography SPECT Heart Diseases Cardiovascular Diseases Arteriosclerosis Myocardial Ischemia Coronary Disease Chest Pain
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
50 (estimated)
Sponsor
Semmelweis University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This prospective study aims to compare functional abnormalities detected using myocardial perfusion SPECT imaging (MPI SPECT) with the extent and severity of anatomical findings on coronary computed tomography angiography (coronary CTA). Additionally, the investigators aim to enhance the diagnostic value of MPI SPECT by quantifying myocardial blood flow and utilizing myocardial flow reserve calcul…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * suspected coronary artery disease * referred to coronary CTA or SPECT MPI by the patient's physician * agrees to the other imaging modality that was not indicated by their physician (coronary CTA or SPECT MPI) * suitable for informed consent Exclusion Criteria: * moderate or…
Contacts

Pál Maurovich-Horvat, Prof. Dr.

+36206632485

maurovich-horvat.pal@semmelweis.hu

CONTACT